Pyrans

Organic heterocyclic compounds that consist of a six-membered ring with five carbon atoms, one oxygen atom, and two double bonds.

Search Within Results

676 – 690 of 1,054 results

676

Aobchem B-[3-(Tetrahydro-2H-pyran-4-yl)phenyl]boronic acid | ≥97% | CAS 2225175-24-4 | C11H15BO3 | 5g

B-[3-(Tetrahydro-2H-pyran-4-yl)phenyl]boronic acid | ≥97% | CAS 2225175-24-4 | C11H15BO3 | 5g

Pricing & Availability

677

Aobchem 1-[4-[(Tetrahydro-2H-pyran-4-yl)oxy]phenyl]ethanone | ≥95% | CAS 1207869-68-8 | C13H16O3 | 250mg

1-[4-[(Tetrahydro-2H-pyran-4-yl)oxy]phenyl]ethanone | ≥95% | CAS 1207869-68-8 | C13H16O3 | 250mg

Pricing & Availability

678

Aobchem 4-Cyanotetrahydro-2H-pyran-4-carboxylic acid | ≥95% | CAS 848821-06-7 | C7H9NO3 | 5g

4-Cyanotetrahydro-2H-pyran-4-carboxylic acid | ≥95% | CAS 848821-06-7 | C7H9NO3 | 5g

Pricing & Availability

679

Medchemexpress LLC MF-DH-300 | 2673403-86-4 | 99.5% | 330.38 | 5 MG

MF-DH-300 is a 15-PGDH inhibitor applicable for research into muscle disorders, such as spinal muscular atrophy (SMA). 15-PGDH (15-Hydroxyprostaglandin dehydrogenase) acts as a tumor suppressor, and its decreased expression is linked to increased tumorigenesis. This inhibitor metabolizes intracellular PGE2, preventing it from binding to EP receptors and thereby suppressing PGE2 signaling.